Navigation Links
Get the Leading Fucoidan Supplement on the go With LIMU ORIGINAL(TM) SHOT

LAKE MARY, Fla., June 1 /PRNewswire/ -- The leading daily Fucoidan supplement, LIMU ORIGINAL™, is now available in a convenient two-ounce pouch as the LIMU ORIGINAL™ SHOT.  LIMU, the recognized marketplace leader of Fucoidan-based products, launched the new packaging as a part of their brand transformation initiatives.  The company has introduced several Fucoidan products into the marketplace, focusing on the marine bioactive's antioxidant, cardiovascular, energy and weight management benefits.  

(Logo: )

"Fucoidan is an incredible supernutrient with proven science that offers wholesome, complete nutrition in today's fast-paced world," said Gary J. Raser, LIMU President and CEO.  "It is our company's privilege and mission to share the rich benefits of Fucoidan, and the LIMU ORIGINAL™ SHOT pouch delivery system gives consumers a chance to enjoy the potent power of LIMU ORIGINAL™ wherever they are, every day."

According to the company, the marine bioactive Fucoidan continues to garner attention as it is used in more and more consumer health products worldwide.  LIMU developed a proprietary extract with scientists familiar with the brown seaweed, limu moui, where Fucoidan is in high concentration, along with 77 additional nutritional elements.  Ongoing studies continue to strengthen Fucoidan's position as an emerging ingredient for a range of health products within the nutritionals industry.

"Our new LIMU ORIGINAL™ SHOT pouches are yet another way for our company to educate the world about Fucoidan's powerful benefits, and we continue to bring the latest developments to the marketplace," said Raser.  The company employs a direct sales business model, allowing all consumers to make additional income selling Fucoidan-based products while efficiently increasing market penetration.  LIMU will work to advance Fucoidan information in upcoming marketing campaigns.  

About LIMU™

LIMU is an established global nutritional company solely focused on marketing the rich health benefits of marine bioactive, Fucoidan.  Employing a direct sales business model, LIMU continues to expand its network of Members across the globe, with tens of millions of dollars in commissions paid. Based in Florida, LIMU is an industry leading home-based business opportunity, helping people to enjoy a higher quality of life. For more information on LIMU and its exclusive Fucoidan product formulas, please visit

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
8. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
10. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma ... planned investment of at least $15.8  Million to ... Wilmington, NC . The expansion will ... to meet the growing demands of the pharmaceutical ... site expansion will provide up to 40,000 ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Henry Schein, ... and services to office-based dental, medical and animal health ... (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion , ... broadest array of open solutions designed to help any ... Click here for a schedule of experts ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... , ... November 27, 2015 , ... Lizzie’s Lice Pickers ... company is offering customers 10% off of their purchase of lice treatment product. In ... full price. According to a company spokesperson. “Finding lice is a sure way to ...
(Date:11/27/2015)... ... ... No.1 Herpes-only dating community in the world, revealed that over 50% of its members are ... people under the age of 50 – or 67% of the population - are infected ... HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by Hollywood legend, ... that are presently affecting Americans. Dedicated to providing the world with a wide variety ... consumers focus on, one episode at a time. , In the latest installment ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
Breaking Medicine News(10 mins):